Article
Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation.
FEBS letters - 20 Apr 2011
Lahti Jennifer L, Lui Bertrand H, Beck Stayce E, Lee Stephen S, Ly Daphne P, Longaker Michael T, Yang George P, Cochran Jennifer R
Abstract excerpt
Receptor tyrosine kinases (RTKs) regulate critical cell signaling pathways, yet the properties of their cognate ligands that influence receptor activation are not fully understood. There is great interest in parsing these complex ligand-receptor relationships using engineered proteins with altered binding properties. Here we focus on the interaction between two engineered epidermal growth factor (EGF) mutants and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
